PLSE Q4 2025 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q4 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$264,000

Gross Profit

-$255,000-96.6% margin

Operating Income

-$18M-6914.0% margin

Net Income

-$17M-6603.4% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+207.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$96M

Total Liabilities

$15M

Stockholders' Equity

$81M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$264,000	$0	—
Gross Profit	-$255,000	$0	—
Operating Income	-$18M	-$20M	+9.9%
Net Income	-$17M	-$19M	+10.1%